Blind-Watermarking—Proof-of-Concept of a Novel Approach to Ensure Batch Traceability for 3D Printed Tablets

Publication date

2022-02

Authors

Windolf, Hellen
Chamberlain, Rebecca
Delmotte, Arnaud
Quodbach, JulianISNI 0000000443513164

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Falsified medicines are a major issue and a threat around the world. Various approaches are currently being investigated to mitigate the threat. In this study, a concept is tested that encodes binary digits (bits) on the surface of Fused Deposition Modelling (FDM) 3D printed geometries. All that is needed is a computer, a FDM 3D printer and a paper scanner for detection. For the experiments, eleven different formulations were tested, covering the most used polymers for 3D printing in pharma: Ethylene-vinyl acetate (EVA), polyvinyl alcohol (PVA), polylactic acid (PLA), Hypromellose (HPMC), ethyl cellulose (EC), basic butylated-methacrylate-copolymer (EPO), and ammonio-methacrylate-copolymer type A (ERL). In addition, the scanning process and printing process were evaluated. It was possible to print up to 32 bits per side on oblong shaped tablets corresponding to the dimensions of market preparations of oblong tablets and capsules. Not all polymers or polymer blends were suitable for this method. Only PVA, PLA, EC, EC+HPMC, and EPO allowed the detection of bits with the scanner. EVA and ERL had too much surface roughness, too low viscosity, and cooled down too slowly preventing the detection of bits. It was observed that the addition of a colorant or active pharmaceutical ingredient (API) could facilitate the detection process. Thus, the process could be transferred for 3D printed pharmaceuticals, but further improvement is necessary to increase robustness and allow use for more materials.

Keywords

Anti-counterfeiting, Blind-watermarking, Falsified medicine, FDM 3D printing, Personalized medicine, Traceability, Pharmaceutical Science

Citation

Windolf, H, Chamberlain, R, Delmotte, A & Quodbach, J 2022, 'Blind-Watermarking—Proof-of-Concept of a Novel Approach to Ensure Batch Traceability for 3D Printed Tablets', Molecular Pharmaceutics, vol. 14, no. 2, 432, pp. 1-17. https://doi.org/10.3390/pharmaceutics14020432